Bosch at Achema - New Manesty TPR Tablet Press Range
At Achema 2015, Bosch Packaging Technology showcases the new range of Manesty TPR tablet presses. Following the introduction of the versatile TPR 500 at last year´s Interpack in Germany, Bosch has now added the TPR 200 for small to medium batches and the TPR 700 for high production volumes to its line-up. Designed to improve Overall Equipment Effectiveness (OEE), all three machines offer an integrated die option, modular powder feeding system and an easy-to-operate Human Machine Interface (HMI).
“The successful launch of the TPR 500 confirms that the new range offers exactly what pharmaceutical manufacturers require,” says John Murphy, product manager at Bosch Packaging Technology in Knowsley, UK. “Based on their feedback, we have now developed two further models to meet the industry’s demands for high yields as well as flexible and efficient production.”
High output and outstanding flexibility
All three tablet presses have been developed to significantly improve OEE in terms of availability, quality and output. Combined with an exchangeable turret, the patented integrated die plate offers increased flexibility, fast, safe and easy changeover, as well as reduced cleaning times. “Depending on the machine model and type of tablets, output capacities are improved by up to 40%,” explains Murphy. Furthermore, the "True Flow" tablet discharge chute eliminates product damage by reducing mechanical stress with an optimized take-off angle for a smooth tablet delivery.
The TPR range also features an extendable powder feeding system, which offers higher flexibility and production efficiency. The ergonomically designed twopaddle feeder can easily be upgraded to three paddles. The simple, precise and repeatable feeder set-up contributes to efficient production. A choice of
rectangular or round paddle blades increases the range of materials that can be compressed.
Efficient and easy operation
The TPR range is easy to operate with a 21-inch HMI touchscreen and Windows 7 as the standard application system. Latest off-the-shelf Beckhoff controls ensure efficient operation as well as simple machine set-up. As part of a total productive maintenance plan, the latest wireless RFID (Radio Frequency Identification Device) technology enables operator log-in and identification at any time, thus significantly reducing the risk of operator errors.
Three machines for different batch sizes
The TPR 500, which was launched at Interpack 2014 in Dusseldorf, Germany, can produce more than 400,000 tablets per hour, using standard tooling on a small footprint. It is particularly suited for MUPS (multiple unit pellet system) products without any additional equipment. “This also demonstrates Bosch’s line
competence, as the pellets can be made on a Hüttlin system and then either enclosed in capsules or pressed as tablets,” Murphy explains.
The new TPR 200 is designed for small to medium batches with outputs of up to 230,000 tablets per hour. “With the TPR 200, we offer customers an economic machine with a hygienic easy-to-clean design and compact footprint,” Murphy says. “Its modular data acquisition system makes it the ideal platform for the development and evaluation of tableting formulations.” Its flexible design includes options for R&D configuration, containment applications, as well as bi-layer tablets. The latter is also available on the new double-sided TPR 700. Both tablet presses can be quickly converted into a bi-layer version that ensures a clear demarcation between the different tablet layers, thus avoiding crosscontamination.
As the largest tablet press of the series, the TPR 700 is capable of producing more than one million tablets per hour. It is suited for a wide range of compressible products including non-pharmaceutical materials such as vitamins. The length of the feeding system provides excellent weight consistency at high speeds. Due to its ergonomic design, both production and technical areas of the tablet press are easily accessible. Moreover, a unique two-level production zone ensures the complete segregation of production and technical areas even when removing the exchangeable turret.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance